Literature DB >> 10376291

Hypoderma lineatum antigen and anti-Przhevalskiana silenus antibodies: cross-reactivity and antibody kinetics in naturally infested goats.

D Otranto1, A Giangaspero, M P Caringella, V Puccini.   

Abstract

To evaluate the cross-reactivity between Hypoderma lineatum antigen and anti-Przhevalskiana silenus antibodies six protocols with different concentrations of antigen and different dilutions of sera and conjugate were applied. The highest cross-reaction between the H. lineatum antigen and the anti-P. silenus antibodies is given by 2 micrograms/ml of antigen concentration, 1:400 of serum and 1:10,000 conjugate dilution. The study on the kinetic development of antibodies in goats naturally infested by P. silenus and the natural course of infestation pointed out the existence of a good correlation between individual antibody kinetics and the natural evolution of the cycle of infestation. The highest antibody concentration may be registered from October through November, coinciding with the end of the migration fo the larvae inside the animal's body. In our condition, this period can be considered as a favorable sampling period for immunodiagnosis and immunoepidemiological studies of goat warble fly infestation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10376291

Source DB:  PubMed          Journal:  Parassitologia        ISSN: 0048-2951


  2 in total

1.  Economic impact of Przhevalskiana silenus infestation in native goats of Northern India.

Authors:  Anish Yadav; Rajesh Katoch; Jitender Kumar Khajuria; Meenu Katoch; Ankur Rastogi
Journal:  Trop Anim Health Prod       Date:  2011-08-04       Impact factor: 1.559

2.  First report of Przhevalskiana silenus derived recombinant hypodermin C based indirect ELISA for serodiagnosis of goat warble fly myiasis.

Authors:  Shafiya Imtiaz Rafiqi; Vikas Yadav; Anish Yadav; Anand Kushwaha; Rajesh Godara; Shilpa Sood; Mohd Altaf Bhat; Rajesh Katoch; Rosario Panadero-Fontán
Journal:  Sci Rep       Date:  2022-08-04       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.